The North American Multiple System Atrophy Study Group

S. Gilman, S. J. May, C. W. Shults, C. M. Tanner, W. Kukull, V. M Y Lee, E. Masliah, P. Low, P. Sandroni, J. Q. Trojanowski, L. Ozelius, Tatiana Foroud

Research output: Contribution to journalArticle

52 Citations (Scopus)

Abstract

The North American Multiple System Atrophy Study Group involves investigators in 12 US medical centers funded by a grant from the National Institutes of Health. The objectives are to examine the environmental and genetic risk factors for MSA; elucidate pathogenic mechanisms underlying the disorder; and refine evaluations used for assessment. During its first year, the group enrolled 87 patients, implemented four cores, and initiated four scientific projects. Most patients among the 87 had parkinsonian features, which frequently began asymmetrically and remained asymmetrical; one-third responded to levodopa and many developed levodopa complications; almost two-thirds of the patients had cerebellar dysfunction, of these 90% had ataxia; urinary incontinence occurred commonly, and sleep disorders affected most. The investigators studied the effects of oxidative and nitrative stress upon the formation of alpha-synuclein inclusions; generated transgenic models of alpha-synuclein accumulation that recapitulate several behavioral and neuropathological features of MSA; and compared the severity of the autonomic features of MSA, Parkinson's disease and dementia with Lewy bodies.

Original languageEnglish
Pages (from-to)1687-1694
Number of pages8
JournalJournal of Neural Transmission
Volume112
Issue number12
DOIs
StatePublished - Dec 2005

Fingerprint

Multiple System Atrophy
alpha-Synuclein
Levodopa
Research Personnel
Cerebellar Diseases
Lewy Body Disease
Organized Financing
National Institutes of Health (U.S.)
Urinary Incontinence
Ataxia
Parkinson Disease
Oxidative Stress

Keywords

  • Autonomic failure
  • Cerebellar ataxia
  • Multiple system atrophy
  • Parkinsonism

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Gilman, S., May, S. J., Shults, C. W., Tanner, C. M., Kukull, W., Lee, V. M. Y., ... Foroud, T. (2005). The North American Multiple System Atrophy Study Group. Journal of Neural Transmission, 112(12), 1687-1694. https://doi.org/10.1007/s00702-005-0381-6

The North American Multiple System Atrophy Study Group. / Gilman, S.; May, S. J.; Shults, C. W.; Tanner, C. M.; Kukull, W.; Lee, V. M Y; Masliah, E.; Low, P.; Sandroni, P.; Trojanowski, J. Q.; Ozelius, L.; Foroud, Tatiana.

In: Journal of Neural Transmission, Vol. 112, No. 12, 12.2005, p. 1687-1694.

Research output: Contribution to journalArticle

Gilman, S, May, SJ, Shults, CW, Tanner, CM, Kukull, W, Lee, VMY, Masliah, E, Low, P, Sandroni, P, Trojanowski, JQ, Ozelius, L & Foroud, T 2005, 'The North American Multiple System Atrophy Study Group', Journal of Neural Transmission, vol. 112, no. 12, pp. 1687-1694. https://doi.org/10.1007/s00702-005-0381-6
Gilman S, May SJ, Shults CW, Tanner CM, Kukull W, Lee VMY et al. The North American Multiple System Atrophy Study Group. Journal of Neural Transmission. 2005 Dec;112(12):1687-1694. https://doi.org/10.1007/s00702-005-0381-6
Gilman, S. ; May, S. J. ; Shults, C. W. ; Tanner, C. M. ; Kukull, W. ; Lee, V. M Y ; Masliah, E. ; Low, P. ; Sandroni, P. ; Trojanowski, J. Q. ; Ozelius, L. ; Foroud, Tatiana. / The North American Multiple System Atrophy Study Group. In: Journal of Neural Transmission. 2005 ; Vol. 112, No. 12. pp. 1687-1694.
@article{97625cdda6cf43f0b7f9ea6955a2ec80,
title = "The North American Multiple System Atrophy Study Group",
abstract = "The North American Multiple System Atrophy Study Group involves investigators in 12 US medical centers funded by a grant from the National Institutes of Health. The objectives are to examine the environmental and genetic risk factors for MSA; elucidate pathogenic mechanisms underlying the disorder; and refine evaluations used for assessment. During its first year, the group enrolled 87 patients, implemented four cores, and initiated four scientific projects. Most patients among the 87 had parkinsonian features, which frequently began asymmetrically and remained asymmetrical; one-third responded to levodopa and many developed levodopa complications; almost two-thirds of the patients had cerebellar dysfunction, of these 90{\%} had ataxia; urinary incontinence occurred commonly, and sleep disorders affected most. The investigators studied the effects of oxidative and nitrative stress upon the formation of alpha-synuclein inclusions; generated transgenic models of alpha-synuclein accumulation that recapitulate several behavioral and neuropathological features of MSA; and compared the severity of the autonomic features of MSA, Parkinson's disease and dementia with Lewy bodies.",
keywords = "Autonomic failure, Cerebellar ataxia, Multiple system atrophy, Parkinsonism",
author = "S. Gilman and May, {S. J.} and Shults, {C. W.} and Tanner, {C. M.} and W. Kukull and Lee, {V. M Y} and E. Masliah and P. Low and P. Sandroni and Trojanowski, {J. Q.} and L. Ozelius and Tatiana Foroud",
year = "2005",
month = "12",
doi = "10.1007/s00702-005-0381-6",
language = "English",
volume = "112",
pages = "1687--1694",
journal = "Journal of Neural Transmission",
issn = "0300-9564",
publisher = "Springer Verlag",
number = "12",

}

TY - JOUR

T1 - The North American Multiple System Atrophy Study Group

AU - Gilman, S.

AU - May, S. J.

AU - Shults, C. W.

AU - Tanner, C. M.

AU - Kukull, W.

AU - Lee, V. M Y

AU - Masliah, E.

AU - Low, P.

AU - Sandroni, P.

AU - Trojanowski, J. Q.

AU - Ozelius, L.

AU - Foroud, Tatiana

PY - 2005/12

Y1 - 2005/12

N2 - The North American Multiple System Atrophy Study Group involves investigators in 12 US medical centers funded by a grant from the National Institutes of Health. The objectives are to examine the environmental and genetic risk factors for MSA; elucidate pathogenic mechanisms underlying the disorder; and refine evaluations used for assessment. During its first year, the group enrolled 87 patients, implemented four cores, and initiated four scientific projects. Most patients among the 87 had parkinsonian features, which frequently began asymmetrically and remained asymmetrical; one-third responded to levodopa and many developed levodopa complications; almost two-thirds of the patients had cerebellar dysfunction, of these 90% had ataxia; urinary incontinence occurred commonly, and sleep disorders affected most. The investigators studied the effects of oxidative and nitrative stress upon the formation of alpha-synuclein inclusions; generated transgenic models of alpha-synuclein accumulation that recapitulate several behavioral and neuropathological features of MSA; and compared the severity of the autonomic features of MSA, Parkinson's disease and dementia with Lewy bodies.

AB - The North American Multiple System Atrophy Study Group involves investigators in 12 US medical centers funded by a grant from the National Institutes of Health. The objectives are to examine the environmental and genetic risk factors for MSA; elucidate pathogenic mechanisms underlying the disorder; and refine evaluations used for assessment. During its first year, the group enrolled 87 patients, implemented four cores, and initiated four scientific projects. Most patients among the 87 had parkinsonian features, which frequently began asymmetrically and remained asymmetrical; one-third responded to levodopa and many developed levodopa complications; almost two-thirds of the patients had cerebellar dysfunction, of these 90% had ataxia; urinary incontinence occurred commonly, and sleep disorders affected most. The investigators studied the effects of oxidative and nitrative stress upon the formation of alpha-synuclein inclusions; generated transgenic models of alpha-synuclein accumulation that recapitulate several behavioral and neuropathological features of MSA; and compared the severity of the autonomic features of MSA, Parkinson's disease and dementia with Lewy bodies.

KW - Autonomic failure

KW - Cerebellar ataxia

KW - Multiple system atrophy

KW - Parkinsonism

UR - http://www.scopus.com/inward/record.url?scp=27744600040&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=27744600040&partnerID=8YFLogxK

U2 - 10.1007/s00702-005-0381-6

DO - 10.1007/s00702-005-0381-6

M3 - Article

VL - 112

SP - 1687

EP - 1694

JO - Journal of Neural Transmission

JF - Journal of Neural Transmission

SN - 0300-9564

IS - 12

ER -